Related by context. Frequent words. (Click for all words.) 74 Elderly Patients 74 Patients Treated 73 Chronic Hepatitis C 72 Clinical Trial Results 72 Advanced Prostate Cancer 72 Well Tolerated 72 Monotherapy 71 Cardiovascular Events 71 Postmenopausal Women 70 Diabetic Patients 70 Prostate Cancer Patients 70 Breast Cancer Patients 70 Phase III Clinical Trial 69 Metastatic Colorectal Cancer 69 Meta Analysis 68 Phase III Trial 68 Completes Enrollment 68 Drug Candidate 68 Combination Therapy 68 Randomized Controlled Trial 68 Drug Resistant 68 Extended Release 68 Heart Failure Patients 68 Induces 67 Increased Risk 67 Breast Cancer Treatment 67 FDA Approves 67 Blood Thinner 67 Significantly Reduces 67 Reduces Risk 67 Cancer Cells 67 Overactive Bladder 67 Smallpox Vaccine 67 Regimens 67 Chronic Heart Failure 67 Pivotal Phase III 67 Study Demonstrates 66 Increases Risk 66 Inhibits 66 Pulmonary Arterial Hypertension 66 Metastatic Melanoma 66 Low Dose 66 Chronic Lymphocytic Leukemia 66 Preclinical Data 66 Benign Prostatic Hyperplasia 66 Prostate Cancer Treatment 66 Solid Tumors 66 Relapsed 66 Tolerability 66 Malaria Vaccine 65 Systematic Review 65 Blood Vessels 65 Cancer Treatments 65 Pivotal Phase 65 Hormone Therapy 65 Allergic Rhinitis 65 FDA Clears 65 Insulin Resistance 64 Cervical Cancer Vaccine 64 Presents Positive 64 Brain Cells 64 Hepatitis C Virus 64 Prostate Cancer Risk 64 Dialysis Patients 64 Shows Promise 64 Acute Myocardial Infarction 64 Cholesterol Drug 64 Study Indicates 64 Monoclonal Antibody 63 Pivotal Trial 63 Patient Enrollment 63 Bladder Cancer 63 Atopic Dermatitis 63 Adalimumab 63 Thyroid Cancer 63 Subcutaneous 63 Brain Tumors 63 Antihypertensive 63 Alcohol Consumption 63 Bird Flu Vaccine 63 Blood Clots 63 Initiates Phase 63 Breast Cancer Risk 63 Inhibit 63 Urinary Incontinence 63 Holds Promise 63 J Am Coll 63 Enoxaparin 62 Multicenter 62 Stroke Risk 62 Immunogenicity 62 Birth Weight 62 Study Confirms 62 Free Full Text 62 FDA Accepts 62 Bevacizumab 62 Int J 62 Flu Vaccines 62 Blood Glucose 62 Natalizumab 62 C Reactive Protein